Comparative Pharmacology
Head-to-head clinical analysis: BAMATE versus MILTOWN.
Peer-Reviewed Evidence
Head-to-head clinical analysis: BAMATE versus MILTOWN.
BAMATE vs MILTOWN
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
The mechanism of action of BAMATE is not well established; it is thought to involve inhibition of monoamine oxidase (MAO) with preferential inhibition of MAO-B at low doses, leading to increased concentrations of dopamine and other biogenic amines in the brain.
Miltown (meprobamate) is a carbamate derivative that acts as a central nervous system depressant. Its mechanism of action is not fully understood, but it is believed to exert its effects by modulating GABAergic neurotransmission, possibly by binding to GABA receptors and enhancing inhibitory neurotransmission. It also has sedative, anxiolytic, and muscle relaxant properties.
400 mg orally twice daily
400 mg orally 3-4 times daily; maximum 2400 mg/day.
None Documented
None Documented
Clinical Note
moderateFelbamate + Estrone sulfate
"The serum concentration of Estrone sulfate can be decreased when it is combined with Felbamate."
Clinical Note
moderateMeprobamate + Fluticasone propionate
"The risk or severity of adverse effects can be increased when Meprobamate is combined with Fluticasone propionate."
Clinical Note
moderateMeprobamate + Haloperidol
"The risk or severity of adverse effects can be increased when Meprobamate is combined with Haloperidol."
Clinical Note
moderateTerminal elimination half-life is 2-4 hours in healthy adults. This short half-life necessitates frequent dosing to maintain therapeutic levels.
10 hours (range 6-17 hours); prolonged in hepatic or renal impairment.
BAMATE is primarily excreted renally as unchanged drug (approximately 60-70%) and as glucuronide conjugates (20-30%). Fecal elimination accounts for less than 10%.
Primarily renal, with 10-20% excreted unchanged; remainder as inactive metabolites (e.g., hydroxymeprobamate). Less than 2% fecal.
Category C
Category C
Anxiolytic
Anxiolytic
Felbamate + Cyclosporine
"The metabolism of Cyclosporine can be decreased when combined with Felbamate."